Skip to Content

Significantly improved pathological complete response with nivolumab + chemotherapy in NSCLC

Jonathan Spicer, Assistant Professor of Surgery, McGill University, Montreal General Hospital, presents in this MEDtalk the results from CheckMate 816, a randomized phase 3 study of neoadjuvant NIVO + chemo vs chemo in resectable NSCLC.

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top